Tatsis Ourania's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 28, 2023
- Accession no.
- 0001209191-23-013765
- Filed
- Feb 28, 2023
- Trade date
- Feb 24-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $101.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tatsis OuraniaCIK 0001789815 | Officer (EVP, Chief Reg. & Quality Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2023 | Common Stock | FTax withholdingDisposed | −3,308 | $289.12 | −$956,408.96 | 57,159 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −283 | $287.20F2,F3 | −$81,277.6 | 56,876 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −51 | $288.33F2,F4 | −$14,704.83 | 56,825 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −20 | $289.29F2,F5 | −$5,785.8 | 56,805 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $287.20 (range $286.71 to $287.60).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $288.33 (range $287.82 to $288.74).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $289.29 (range $289.17 to $289.40).
Referenced by the price of 1 transaction in Table I.